AQST
Aquestive Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Aquestive Therapeutics (AQST) Stock: Buy, Sell, or Hold?
$3.58
+0.06 (+1.70%)
▲
5d:
-5.79%
30d:
-23.34%
90d:
-15.76%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (95%)
Quality Score
62/100
Position
OVERSOLD
30-Day Fair Range
$3.70 – $4.51
Position: OVERSOLD
Forward P/E & Valuation
-6.3x
Next 12M consensus est.
Wall Street Target
$9.33
+160.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.37 / $4.29
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: AQST shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When AQST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: AQST is currently trading at $3.58, which is considered oversold relative to its 30-day fair value range of $3.70 to $4.51.
Technical Outlook: Technically, AQST is in a strong uptrend. Immediate support is located at $3.37, while resistance sits at $4.29.
Market Sentiment: AQST scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.33 (+160.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AQST is in a strong uptrend. Immediate support is located at $3.37, while resistance sits at $4.29.
Market Sentiment: AQST scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.33 (+160.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.70 -
$4.51
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$3.70 -
$4.51
Current vs Trading Range
OVERSOLD
Support Level
$3.37
Resistance Level
$4.29
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 160.7% below Wall St target ($9.33)
- CAUTION: Bottoming setup, but lagging the sector by 12% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-5.8%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
-6.28
Wall Street Target
$9.33
(+160.7%)
Revenue Growth (YoY)
-41.0%
Profit Margin
-162.3%
Share AQST Analysis
Share this live AQST analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (AQST)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages express bullish sentiment towards $AQST, despite recent price decline. No new information from Yahoo Finance news.
Key Retail Themes:
Frustration with stock price decline
Speculation about insider information
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:09 AM ET
Data refreshes hourly during market hours. Next update: 2:09 AM
Data refreshes hourly during market hours. Next update: 2:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AQST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 33 SELL |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$687 | 52 HOLD |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 53 HOLD |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 34 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive AQST Research Pages